Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Lithuania
Lithuania: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.1% in 2024. ▬ Flat
Latest (2024)
0.1%
Change on year
unchanged
World rank
112th
of 215 countries
All-time high
0.1%
in 2015
All-time low
0.1%
in 2015
Years of data
10
2015–2024
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Lithuania, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Lithuania stood at 0.1%. That is the highest value across all 10 years on record.
That represents a change of unchanged over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Lithuania peaked at 0.1% in 2015 and was at its lowest, 0.1%, in 2015.
That places Lithuania 112th out of 215 countries with data for 2024, putting it in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Lithuania, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.1% | +0.0% |
| 2017 | 0.1% | +0.0% |
| 2018 | 0.1% | +0.0% |
| 2019 | 0.1% | +0.0% |
| 2020 | 0.1% | +0.0% |
| 2021 | 0.1% | +0.0% |
| 2022 | 0.1% | +0.0% |
| 2023 | 0.1% | +0.0% |
| 2024 | 0.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.1% | 5 |
| 2020s | 0.1% | 0.1% | 0.1% | 5 |
Countries ranked near Lithuania
- 112 Albania 0.1% compare
- 112 Algeria 0.1% compare
- 112 Armenia 0.1% compare
- 112 Australia 0.1% compare
- 112 Belize 0.1% compare
- 112 Bhutan 0.1% compare
- 112 China 0.1% compare
- 112 Denmark 0.1% compare
- 112 Dominican Republic 0.1% compare
- 112 Gambia 0.1% compare
- 112 Guam 0.1% compare
- 112 Guyana 0.1% compare
- 112 Hungary 0.1% compare
- 112 Israel 0.1% compare
- 112 Jordan 0.1% compare
- 112 Kyrgyzstan 0.1% compare
- 112 Lebanon 0.1% compare
- 112 Malaysia 0.1% compare
- 112 Oman 0.1% compare
- 112 Paraguay 0.1% compare
- 112 Peru 0.1% compare
- 112 Romania 0.1% compare
- 112 Russian Federation 0.1% compare
- 112 Serbia 0.1% compare
- 112 Singapore 0.1% compare
- 112 Thailand 0.1% compare
- 112 Trinidad and Tobago 0.1% compare
- 112 Tunisia 0.1% compare
- 112 Ukraine 0.1% compare
- 112 Uzbekistan 0.1% compare
More development goals data for Lithuania
- Red List Index 0.9919 (2025)
- Number of refugees per 100,000 population, by country of origin 3.75 (2025)
- Manufacturing value added per capita 3,802 (2025)
- Number of transboundary breeds 63 (2025)
- Number of transboundary breeds (not extinct) 62 (2025)
- Number of transboundary breeds with unknown risk status 24 (2025)
- Number of local breeds with unknown risk status 6 (2025)
- Number of local breeds (not extinct) 29 (2025)
- Number of local breeds kept in the country 29 (2025)
- Infant deaths 62 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Lithuania?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Lithuania was 0.1% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Lithuania?
- The highest recorded value was 0.1% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Lithuania?
- The lowest recorded value was 0.1% in 2015.
- How does Lithuania rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Lithuania ranks 112th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Lithuania?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Lithuania data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).